(Q43936563)

English

Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ott EA

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Mazzoleni LE

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Edelweiss MI

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sander GB

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Wortmann AC

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Theil AL

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Somm G

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Cartell A

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Rivero LF

9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Uchôa DM

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Francesconi CF

11

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Prolla JC

12

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1231-1239

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Helicobacter pylori infection and the development of gastric cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02461.X

21 January 2018

Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1046/J.1365-2036.2003.01665.X

Identifiers

10.1111/J.1365-2036.2005.02461.X

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43936563&oldid=2104507559"